Virion Biotherapeutics

Virion Biotherapeutics is a developer of biological antivirals aimed at improving therapeutics for respiratory viral infections. The company specifically focuses on the prevention and treatment of influenza and respiratory syncytial virus (RSV). By offering broad-spectrum therapies for these infections, Virion seeks to simplify and accelerate treatment processes for healthcare providers, eliminating the need for differential diagnosis. Through its innovative approach, Virion Biotherapeutics aims to enhance patient care in the realm of respiratory illnesses.